Your SlideShare is downloading. ×
Lessons Learned: The FDA.gov Redesign / Forum One Web Executive Seminar
Lessons Learned: The FDA.gov Redesign / Forum One Web Executive Seminar
Lessons Learned: The FDA.gov Redesign / Forum One Web Executive Seminar
Lessons Learned: The FDA.gov Redesign / Forum One Web Executive Seminar
Lessons Learned: The FDA.gov Redesign / Forum One Web Executive Seminar
Lessons Learned: The FDA.gov Redesign / Forum One Web Executive Seminar
Lessons Learned: The FDA.gov Redesign / Forum One Web Executive Seminar
Lessons Learned: The FDA.gov Redesign / Forum One Web Executive Seminar
Lessons Learned: The FDA.gov Redesign / Forum One Web Executive Seminar
Lessons Learned: The FDA.gov Redesign / Forum One Web Executive Seminar
Lessons Learned: The FDA.gov Redesign / Forum One Web Executive Seminar
Lessons Learned: The FDA.gov Redesign / Forum One Web Executive Seminar
Lessons Learned: The FDA.gov Redesign / Forum One Web Executive Seminar
Lessons Learned: The FDA.gov Redesign / Forum One Web Executive Seminar
Lessons Learned: The FDA.gov Redesign / Forum One Web Executive Seminar
Lessons Learned: The FDA.gov Redesign / Forum One Web Executive Seminar
Lessons Learned: The FDA.gov Redesign / Forum One Web Executive Seminar
Lessons Learned: The FDA.gov Redesign / Forum One Web Executive Seminar
Lessons Learned: The FDA.gov Redesign / Forum One Web Executive Seminar
Lessons Learned: The FDA.gov Redesign / Forum One Web Executive Seminar
Lessons Learned: The FDA.gov Redesign / Forum One Web Executive Seminar
Lessons Learned: The FDA.gov Redesign / Forum One Web Executive Seminar
Lessons Learned: The FDA.gov Redesign / Forum One Web Executive Seminar
Lessons Learned: The FDA.gov Redesign / Forum One Web Executive Seminar
Lessons Learned: The FDA.gov Redesign / Forum One Web Executive Seminar
Lessons Learned: The FDA.gov Redesign / Forum One Web Executive Seminar
Lessons Learned: The FDA.gov Redesign / Forum One Web Executive Seminar
Lessons Learned: The FDA.gov Redesign / Forum One Web Executive Seminar
Lessons Learned: The FDA.gov Redesign / Forum One Web Executive Seminar
Lessons Learned: The FDA.gov Redesign / Forum One Web Executive Seminar
Lessons Learned: The FDA.gov Redesign / Forum One Web Executive Seminar
Lessons Learned: The FDA.gov Redesign / Forum One Web Executive Seminar
Lessons Learned: The FDA.gov Redesign / Forum One Web Executive Seminar
Lessons Learned: The FDA.gov Redesign / Forum One Web Executive Seminar
Lessons Learned: The FDA.gov Redesign / Forum One Web Executive Seminar
Lessons Learned: The FDA.gov Redesign / Forum One Web Executive Seminar
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Lessons Learned: The FDA.gov Redesign / Forum One Web Executive Seminar

3,831

Published on

Sanjay Koyani, Director, FDA Web Communications</itunes:author> …

Sanjay Koyani, Director, FDA Web Communications</itunes:author>
<itunes:subtitle>Lessons Learned: The FDA.gov Redesign</itunes:subtitle>
<itunes:summary>Sanjay Koyani, Director, FDA Web Communications, speaks at Forum One's Web Executive Seminar, "Putting Online Audiences First, Again and Again" on May 8, 2008. To learn more about this event, visit http://ow.ly/oY7y . Contact: Sophie Campagne / scampagne@ForumOne.com .

1 Comment
3 Likes
Statistics
Notes
  • Fioricet is often prescribed for tension headaches caused by contractions of the muscles in the neck and shoulder area. Buy now from http://www.fioricetsupply.com and make a deal for you.
       Reply 
    Are you sure you want to  Yes  No
    Your message goes here
No Downloads
Views
Total Views
3,831
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
0
Comments
1
Likes
3
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide
  • Transcript

    • 1. Lessons Learned: FDA.gov Redesign May 8, 2008 Sanjay J. Koyani Director of Web Communications U.S. Food and Drug Administration
    • 2. Web Executive Seminars Putting Online Audiences First, Again and Again May 8, 2008 National Press Club Washington, DC Learn more: www.forumone.com/wes
    • 3. Lessons Learned: FDA.gov Redesign May 8, 2008 Sanjay J. Koyani Director of Web Communications U.S. Food and Drug Administration
    • 4. Get Buy-In: Top Down
      • June ’07 Commissioner Memo: “FDA Web Communications in the 21 st Century”
      • “ Our goal is to transform FDA.gov to a gold standard among federal sites. By creating a single online identity that more fully supports the agency mission, we will strengthen all FDA Center and Office sites. Together we will create an FDA Web presence that is:
        • Person-centric;
        • Informative;
        • Empowering; and
        • Interactive.”
    • 5. Get Buy-In: Bottom Up
      • Commissioned Audit of FDA Web Staffs
      • Web staffs wanted:
        • Centralized Web governance
        • Policies, Standards, and coding guidance
        • More uniform publishing systems
        • Coordinated Web communications to reduce risk and embarrassment to agency
    • 6. Get Buy-In: External Support
    • 7. Educate on FDA’s “Gold Standard” Approach to Web Design
    • 8. Practice Research
    • 9.  
    • 10.  
    • 11. Increase Web Site Credibility
      • A physical address is provided on the homepage and all major points of entry
      • Frequently ask questions are provided AND are useful
    • 12. Increase Web Site Credibility
      • Organization providing the information is highly visible
      • Site is arranged in a logical way
      • Provides phone numbers
      • Dates are provided up-front and are kept current
    • 13. Placement of Instructional Text
    • 14. Placement of Instructional Text
      • Users’ focus is pulled almost immediately to the User Name field (they are motivated to take an action)
      • Jumping immediately to that field causes the user to leapfrog over the instructional text
      • Once downstream of the instructional text
        • Users’ are unlikely to go back and read it, even if unsure of what the requirements are
        • Users make a best guess and move on, attracted by the radio buttons
    • 15. Guidelines for Instructional Text
      • Divide dense instructions up for individual action objects
      • Put the appropriate instructions in close proximity to their respective action objects
      • Place the instructional text next to the corresponding action object, preferably in the downstream direction , to the right or just below it
      • If the instructional text is too long and its recommended placement would disrupt the layout of the action objects, provide a link that dynamically displays a pop-up when clicked
    • 16. Allow Simple Searches 11 58 33
    • 17. User-Centered Design Process
    • 18. Redesign Activities
      • Developed Web Governance Team tasked with guiding redesign effort
      • Developed Strategic plan and timeline detailing our evolutionary approach to Web
      • Determined agency resources , need for contract specialists , etc.
    • 19. Redesign Activities
      • Assessed FDA.gov’s top tasks, audiences, and needs with the FIT
      • • Conducted competitive analysis of top health Web sites in industry and government
      • • Reviewed past usability test reports & evaluations conducted on FDA.gov
    • 20. Redesign Activities
      • Performed card sorting exercises with 130 users, including the public, health professionals, and industry
      • • Developed several FDA.gov homepage prototypes
    • 21.  
    • 22.  
    • 23.  
    • 24. Redesign Activities • Usability tested the FDA.gov prototypes via multiple usability tests, both on site at FDA, and remotely with 58 members of public, health professionals, and industry
    • 25. What We Measured in Usability Testing
    • 26. Rapid Reporting via Automated Usability Testing Tool
    • 27. Rapid Reporting via Automated Usability Testing Tool
    • 28.  
    • 29.  
    • 30. Does Progressive Layering Improve Performance?
    • 31. Fly-Out Example
    • 32. Lessons Learned
    • 33. What’s Next
      • Build-out templates and IA for all FDA.gov pages
      • Usability test template designs with users to ensure validity
      • Conduct content audit and expand Web writing skills
      • Migrate content and designs into an automated Web content management system
      • Continual site improvements planned around FDA top tasks
    • 34. Resources/Tools
      • Usability.gov: www.usability.gov
      • Research-Based Web Design & Usability Guidelines: http://www.usability.gov/pdfs/guidelines.html
      • Webcontent.gov: www.webcontent.gov
      • Automated Usability Testing Tool: http://www.mindd.com/Content.aspx?pid=UTEStandard
      • NIST Common Industry Format: http://zing.ncsl.nist.gov/iusr/documents/cifv1.1b.htm#_Toc467573702
    • 35. Questions ?
      • CONTACT INFORMATION
      • Sanjay Koyani, U.S. Food and Drug Administration
      • Email: Sanjay.koyani@fda.hhs.gov
      • Phone: 301.827.7131
    • 36. LEARN MORE: www.forumone.com/wes Web Executive Seminars

    ×